Supernus Pharmaceuticals ... (SUPN)
NASDAQ: SUPN
· Real-Time Price · USD
43.22
1.05 (2.49%)
At close: Aug 15, 2025, 12:41 PM
Supernus Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 22.5M | -11.83M | 15.33M | 38.5M | 19.92M | 124K | 1.18M | -15.98M | -831K | 16.95M | 25.48M | 1.75M | 7.87M | 25.62M | 2.44M | 21.56M | 23.73M | 5.69M |
Depreciation & Amortization | 21.32M | 20.38M | 18.84M | 20.09M | 20.71M | 20.75M | 21.68M | 21.86M | 20.73M | 20.6M | 20.85M | 21.77M | 21.56M | 21.36M | 12.71M | 6.67M | 6.62M | 6.59M |
Stock-Based Compensation | 7.51M | 8.07M | 7.63M | 7.67M | 6.55M | 5.9M | 6.45M | 7.92M | 6.09M | 6.31M | 4.26M | 4.99M | 4.3M | 4.03M | 4.04M | 4.03M | 5.48M | 4.37M |
Other Working Capital | 8.28M | 8.8M | -11.23M | -7.75M | 8.62M | 5.43M | -395K | 34.05M | -27.23M | -9.57M | 2.4M | 13.94M | 6.38M | 6.42M | 3.6M | -36.9M | 27.23M | 2.18M |
Other Non-Cash Items | 10.39M | 4.06M | 7.8M | 1.61M | 58.96M | 42.21M | 24.15M | 1.67M | 6.9M | 288K | 1.8M | 12.33M | -1K | -11.97M | 5.32M | 6.64M | -4.52M | 17.18M |
Deferred Income Tax | -7.16M | -3.99M | -72K | -6.47M | -8.12M | -5.48M | -10.46M | -9.27M | -5.55M | -435K | -7.76M | -2.51M | -3.05M | -13.01M | -4.51M | 1.57M | 519K | -2.56M |
Change in Working Capital | 11.49M | 13.91M | -5.13M | -7.88M | -2.9M | 13.87M | 1.97M | 29.67M | -46.2M | 5.42M | -17.07M | -24.49M | 39.03M | -21.72M | 28.77M | -44.58M | 14.45M | 4.92M |
Operating Cash Flow | 58.53M | 30.6M | 44.41M | 53.52M | 35.62M | 38.4M | 44.96M | 35.88M | -18.87M | 49.13M | 27.56M | 13.84M | 71.12M | 4.3M | 48.76M | -4.11M | 46.27M | 36.2M |
Capital Expenditures | -455K | -327K | -213K | -200K | -64K | -248K | 36K | -150K | -159K | -278K | 861K | -147K | 576K | -851K | -40K | -497K | n/a | -1.51M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 82.08M | n/a | n/a | -310.74M | n/a | -950K | n/a |
Purchase of Investments | -140.56M | -118.56M | -145.41M | -224.93M | -123.98M | -193.7M | -101.62M | n/a | n/a | n/a | -66.33M | -134.16M | -108.44M | -98.06M | -3.94M | -74.36M | -114.21M | -119.06M |
Sales Maturities Of Investments | 110.4M | 156.2M | 132.98M | 148.11M | 75.45M | 142.32M | 35.6M | 34.78M | 60.45M | 240.06M | 17.55M | 52.08M | 92.19M | 28.93M | 377.96M | 68.7M | 34.27M | 49.58M |
Other Investing Acitivies | n/a | n/a | n/a | 9K | -48.53M | -51.38M | n/a | 34.78M | 60.45M | 240.06M | -851K | -82.08M | -16.25M | -69.14M | 12.89M | 453K | -950K | -453K |
Investing Cash Flow | -30.61M | 37.32M | -12.64M | -77.01M | -48.59M | -51.62M | -65.98M | 34.63M | 60.3M | 239.78M | -48.77M | -82.23M | -15.68M | -69.99M | 76.13M | -5.7M | -80.89M | -71.44M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -480.86M | 78.36M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -2.34M | -23.44M | -987K | -387K | -1K | -1.34M | -1.99M | n/a | -575K | -445K | n/a | n/a | n/a | -22.9M | -138.31M | 1.32M | n/a | n/a |
Financial Cash Flow | 935K | -21.4M | 5.89M | 3.08M | 1.66M | 1.57M | 1.09M | -230K | -478.92M | 80.17M | 2.83M | 6.46M | 2.27M | -22.03M | -136.74M | 1.32M | 2.75M | 2.25M |
Net Cash Flow | 28.86M | 46.52M | 37.66M | -20.42M | -11.31M | -11.65M | -19.93M | 70.28M | -437.49M | 369.08M | -18.37M | -61.94M | 57.71M | -87.72M | -11.85M | -8.49M | -31.87M | -33M |
Free Cash Flow | 58.08M | 30.27M | 44.19M | 53.32M | 35.56M | 38.15M | 44.99M | 35.73M | -19.03M | 48.85M | 28.43M | 13.69M | 71.69M | 3.45M | 48.72M | -4.61M | 46.27M | 34.69M |